Study underscores the utility of Neuropad® as a non-invasive, reliable tool for early detection of diabetic neuropathy

The article titled “Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus” (Ishibashi et al., 2014) explores the relationship between sudomotor function, sweat gland duct size, and corneal nerve fibre pathology in patients with type 2 diabetes.

In a pivotal 2014 study published in Journal of Diabetes Investigation, Ishibashi et al. examined the correlation between sudomotor function, sweat gland duct size, and corneal nerve fibre pathology in patients with type 2 diabetes mellitus. The study involved 78 patients with type 2 diabetes and 28 control participants. Sudomotor function was assessed using the Neuropad test, which measures sweat gland activity through a colour change in the indicator plaster. The results indicated that patients with diabetic neuropathy exhibited impaired sudomotor function compared to controls, with the severity of impairment correlating with the stage of diabetic neuropathy. Additionally, the study found that sweat gland ducts were smaller in diabetic patients, and this reduction in size was more pronounced in those with severe neuropathy. The findings suggest that sudomotor dysfunction, as assessed by Neuropad, is an early indicator of diabetic neuropathy and is associated with structural changes in sweat glands and corneal nerve fibres.

This study underscores the utility of Neuropad as a non-invasive, reliable tool for early detection of diabetic neuropathy. Its simplicity and ease of use make it an excellent option for routine screening in clinical settings, allowing for timely intervention and management of diabetic neuropathy.

Key Points:

  • Early Detection: Neuropad effectively identifies early signs of diabetic neuropathy through sudomotor function assessment.
  • Non-Invasive: The test is simple to administer and does not require specialized equipment.
  • Clinical Utility: Neuropad’s ease of use facilitates its integration into routine clinical practice for monitoring diabetic patients.
  • Reliability: The study demonstrated a strong correlation between Neuropad results and structural changes in sweat glands and corneal nerve fibres.

Conclusion:

Ishibashi et al.’s study highlights the importance of early detection of diabetic neuropathy and supports the use of Neuropad as a valuable tool in this regard. Its non-invasive nature, ease of use, and reliability make it a promising option for enhancing patient care and outcomes in individuals with diabetes.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4188118/pdf/jdi-5-588.pdf